BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership4,512,634 shares
Latest Disclosed Value $ 254,918,695
Citadel Advisors Llc ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 4,512,634 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $254,918,695 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,364,691 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 230.67% during the quarter. The current value of the position is $256,182,232 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 128,800 of underlying shares valued at $7,275,912 USD and put options representing 56,400 of underlying shares valued at $3,186,036 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,512,634 3,147,943 230.67 254,919 214.31 0.0412
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,364,691 966,844 243.02 81,104 276.40 0.0122
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 397,847 62,827 18.75 21,547 17.00 0.0033
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 335,020 -1,260,038 -79.00 18,416 -83.67 0.0032
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,595,058 1,207,445 311.51 112,755 342.57 0.0214
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 387,613 -816,784 -67.82 25,478 -69.91 0.0044
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,204,397 646,545 115.90 84,657 84.33 0.0163
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 557,852 -1,417,706 -71.76 45,928 -73.38 0.0093
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,975,558 1,620,613 456.58 172,545 404.18 0.0333
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 354,945 213,413 150.79 34,224 173.30 0.0068
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 141,532 -340,807 -70.66 12,523 -70.05 0.0027
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 482,339 358,771 290.34 41,809 247.97 0.0086
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 123,568 -6,933 -5.31 12,016 -11.03 0.0026
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 130,501 -871,813 -86.98 13,506 -84.11 0.0032
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,002,314 -150,761 -13.07 84,966 -11.08 0.0194
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,153,075 -937,328 -44.84 95,555 -40.71 0.0245
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,090,403 732,488 53.94 161,170 34.34 0.0333
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,357,915 1,308,848 2,667.47 119,972 3,062.98 0.0245
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 49,067 -911,095 -94.89 3,793 -95.27 0.0008
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 960,162 -673,518 -41.23 80,116 -35.06 0.0179
2021-05-21 2021-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,633,680 -1,361,590 -45.46 123,360 -53.03 0.0303
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,633,680 -1,361,590 123,360 0.0303
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,995,270 517,914 20.91 262,655 39.36 0.0683
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,477,356 2,222,384 871.62 188,477 499.33 0.0535
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 254,972 -4,355 -1.68 31,448 43.51 0.0112
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 259,327 -1,780,826 -87.29 21,913 -87.30 0.0098
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 2,040,153 282,923 16.10 172,495 45.64 0.0748
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,757,230 587,616 50.24 118,438 18.23 0.0559
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,169,614 40,966 3.63 100,177 -0.08 0.0459
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,128,648 -229,037 -16.87 100,258 -13.28 0.0499
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,357,685 -1,101,023 -44.78 115,607 -51.51 0.0633
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 2,458,708 625,303 34.11 238,421 38.05 0.1069
2018-08-14 2018-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,833,405 457,896 33.29 172,707 54.88 0.0854
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,833,405 457,896 172,707
2018-05-14 2018-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,375,509 -939,566 -40.58 111,513 -45.98 0.0613
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,375,509 -939,566 111,513
2018-02-09 2017-12-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 2,315,075 671,639 40.87 206,435 34.97 0.1256
2017-11-09 2017-09-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,643,436 1,401,415 579.05 152,954 595.85 0.1174
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 242,021 -224,884 -48.16 21,981 -46.37 0.0186
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 466,905 -233,832 -33.37 40,985 -29.40 0.0375
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL Cmn 09061G101 700,737 -272,548 -28.00 58,049 -35.54 0.0586
2017-01-31 2016-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL Cmn 09061G101 973,285 -680,698 -41.16 90,048 -30.02 0.0905
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 973,285 90,048
2017-01-31 2016-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL Cmn 09061G101 1,653,983 -540,892 -24.64 128,680 -28.92 0.1434
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 1,653,983 128,680
2017-01-31 2016-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL Cmn 09061G101 2,194,875 2,121,458 2,889.60 181,033 2,253.83 0.2284
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 2,194,875 181,033
2017-01-31 2015-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL Cmn 09061G101 73,417 -353,165 -82.79 7,691 -82.88 0.0084
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 73,417 7,691
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 426,582 -153,235 -26.43 44,927 -43.35 0.0433
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 579,817 -385,389 -39.93 79,308 -34.07 0.0695
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 965,206 -492,997 -33.81 120,284 -8.75 0.1339
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 1,458,203 256,311 21.33 131,822 51.99 0.1595
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 1,201,892 634,138 111.69 86,729 145.55 0.1087
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 567,754 -69,792 -10.95 35,320 -18.78 0.0478
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 637,546 89,804 16.40 43,487 12.99 0.0600
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 547,742 80,715 17.28 38,489 14.11 0.0501
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 467,027 -419,963 -47.35 33,729 -31.84 0.0515
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn 09061G101 886,990 886,990 49,485 0.0855
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 128,800 -38.37 7,276 -41.43 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 209,000 -1.51 12,421 8.08 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 212,200 9.38 11,493 7.76 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 194,000 25.65 10,664 -2.29 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 154,400 61.84 10,915 74.07 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 95,400 -30.26 6,271 -34.79 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 136,800 -26.49 9,616 -37.24 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 186,100 205.58 15,322 188.04 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 60,900 -35.01 5,319 -41.12 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 93,700 54.37 9,035 68.23 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 60,700 -32.10 5,371 -30.70 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 89,400 -30.80 7,749 -38.32 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 129,200 -3.44 12,563 -9.27 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 133,800 14.26 13,847 39.48 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 117,100 9.64 9,927 12.16 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 106,800 -5.15 8,851 1.96 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 112,600 -23.40 8,681 -33.16 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 147,000 -36.14 12,987 -27.01 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 230,200 43.96 17,792 33.35 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 159,900 17.40 13,342 29.74 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 136,200 -41.52 10,284 -49.65 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 136,200 10,284 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 232,900 40.56 20,423 62.01 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 165,700 6.42 12,606 -34.36 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 155,700 89.19 19,204 176.16 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 82,300 -37.56 6,954 -37.60 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 131,800 141.39 11,144 202.83 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 54,600 -31.23 3,680 -45.89 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 79,400 -23.65 6,801 -26.38 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 104,000 30.49 9,238 36.13 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 79,700 21.31 6,786 6.51 n/a n/a n/a
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 65,700 12.89 6,371 16.22 n/a n/a n/a
2018-08-14 2018-06-30 13F/A BIOMARIN PHARMACEUTICAL Cmn Call 58,200 44.06 5,482 67.39 n/a n/a n/a
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 58,200 5,482 n/a n/a n/a
2018-05-14 2018-03-31 13F/A BIOMARIN PHARMACEUTICAL Cmn Call 40,400 17.44 3,275 6.78 n/a n/a n/a
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 40,400 3,275 n/a n/a n/a
2018-02-09 2017-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 34,400 12.79 3,067 8.03 n/a n/a n/a
2017-11-09 2017-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 30,500 8.54 2,839 11.25 n/a n/a n/a
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Call 28,100 -8.47 2,552 -5.31 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 30,700 3.02 2,695 9.15 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Call 29,800 -15.10 2,469 -23.96 n/a n/a n/a
2017-01-31 2016-09-30 13F/A BIOMARIN PHARMACEUTICAL Cmn Call 35,100 37.65 3,247 63.66 n/a n/a n/a
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 35,100 3,247 n/a n/a n/a
2017-01-31 2016-06-30 13F/A BIOMARIN PHARMACEUTICAL Cmn Call 25,500 -31.08 1,984 -34.99 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 25,500 1,984 n/a n/a n/a
2017-01-31 2016-03-31 13F/A BIOMARIN PHARMACEUTICAL Cmn Call 37,000 4.23 3,052 -17.93 n/a n/a n/a
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 37,000 3,052 n/a n/a n/a
2017-01-31 2015-12-31 13F/A BIOMARIN PHARMACEUTICAL Cmn Call 35,500 38.67 3,719 37.95 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 35,500 3,719 n/a n/a n/a
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 25,600 -49.11 2,696 -60.81 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 50,300 -33.29 6,880 -26.78 n/a n/a n/a
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 75,400 12.87 9,396 55.59 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 66,800 13.61 6,039 42.33 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 58,800 -59.92 4,243 -53.51 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 146,700 290.16 9,126 255.79 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 37,600 -23.11 2,565 -25.35 n/a n/a n/a
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 48,900 103.75 3,436 98.27 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 24,000 -28.57 1,733 -7.57 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Call 33,600 1,875 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 56,400 -44.98 3,186 -47.69 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 102,500 5.89 6,092 16.20 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 96,800 2.54 5,243 1.02 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 94,400 -49.52 5,189 -60.75 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 187,000 -35.78 13,219 -30.94 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 291,200 12.26 19,141 4.97 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 259,400 -22.84 18,233 -34.13 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 336,200 192.09 27,679 175.36 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 115,100 16.38 10,053 5.42 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 98,900 -69.71 9,536 -66.99 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 326,500 53.65 28,889 56.84 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 212,500 11.49 18,420 -0.62 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 190,600 110.61 18,534 97.90 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 90,500 -62.09 9,366 -53.72 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 238,700 -7.30 20,235 -5.17 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 257,500 180.50 21,339 201.48 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 91,800 -28.56 7,078 -37.66 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 128,500 -58.40 11,353 -52.45 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 308,900 62.84 23,875 50.83 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 189,700 -16.76 15,829 -8.02 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 227,900 10.58 17,209 -4.78 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 227,900 17,209 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 206,100 -37.72 18,073 -28.21 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 330,900 65.95 25,175 2.36 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 199,400 59.14 24,594 132.28 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 125,300 99.21 10,588 99.10 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 62,900 67.29 5,318 109.87 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 37,600 -65.79 2,534 -73.08 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 109,900 -28.59 9,413 -31.15 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 153,900 145.06 13,671 155.68 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 62,800 -40.25 5,347 -47.54 n/a n/a n/a
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 105,100 39.76 10,192 43.87 n/a n/a n/a
2018-08-14 2018-06-30 13F/A BIOMARIN PHARMACEUTICAL Cmn Put 75,200 56.67 7,084 82.06 n/a n/a n/a
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 75,200 7,084 n/a n/a n/a
2018-05-14 2018-03-31 13F/A BIOMARIN PHARMACEUTICAL Cmn Put 48,000 -16.81 3,891 -24.37 n/a n/a n/a
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 48,000 3,891 n/a n/a n/a
2018-02-09 2017-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 57,700 55.11 5,145 48.61 n/a n/a n/a
2017-11-09 2017-09-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 37,200 28.28 3,462 31.48 n/a n/a n/a
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL Cmn Put 29,000 47.21 2,633 52.28 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 19,700 -18.93 1,729 -14.11 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL Cmn Put 24,300 -36.55 2,013 -43.20 n/a n/a n/a
2017-01-31 2016-09-30 13F/A BIOMARIN PHARMACEUTICAL Cmn Put 38,300 187.97 3,544 242.42 n/a n/a n/a
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 38,300 3,544 n/a n/a n/a
2017-01-31 2016-06-30 13F/A BIOMARIN PHARMACEUTICAL Cmn Put 13,300 -2.21 1,035 -7.75 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 13,300 1,035 n/a n/a n/a
2017-01-31 2016-03-31 13F/A BIOMARIN PHARMACEUTICAL Cmn Put 13,600 -26.09 1,122 -41.80 n/a n/a n/a
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 13,600 1,122 n/a n/a n/a
2017-01-31 2015-12-31 13F/A BIOMARIN PHARMACEUTICAL Cmn Put 18,400 -34.98 1,928 -35.32 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 18,400 1,928 n/a n/a n/a
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 28,300 -18.68 2,981 -37.37 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 34,800 -29.41 4,760 -22.53 n/a n/a n/a
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 49,300 137.02 6,144 226.81 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 20,800 11.83 1,880 40.09 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 18,600 -37.79 1,342 -27.85 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 29,900 -16.01 1,860 -23.39 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 35,600 -20.00 2,428 -22.35 n/a n/a n/a
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 44,500 37.35 3,127 33.63 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 32,400 -55.31 2,340 -42.15 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL INC CMN STOCK Cmn Put 72,500 4,045 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.